The Food and Drug Administration announced that Philips recalled the software following 109 reported injuries and two reported deaths.

Philips will sell its emergency care business to investment firm Bridgefield Capital for an undisclosed amount. The deal is ...

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect ...

Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed by healthcare professionals due to a data routing issue.

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, ...

At least two deaths and over a hundred injuries have been linked to a malfunctioning heart monitoring device from Philips and its subsidiary, Braemer. The company affirmed in a statement that that the ...

Philips recalls software for mobile cardiac telemetry devices after patient injuries and deaths. Urgent medical device correction issued. Class I recall.

Philips' smart systems and intelligent software showcased at Arab Health 2025 is developed to enable predictability, collaboration, precision, and integration to deliver better care for more people ...

Another 109 people reported injuries after using the remote cardiac monitoring software, Modern Healthcare reported. Other pharmaceutical and tech news is on the FDA's drug approval system and a rapid ...

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation ...

A complex cardiac MRI exam can take ... image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs ...

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic today announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic ...